Results 241 to 250 of about 47,262 (255)
Some of the next articles are maybe not open access.
Sirtuins in mechanistic target of rapamycin complex 1 signaling
2021J. Burillo +5 more
openaire +1 more source
Background: Bevacizumab is a widely used anti-VEGF-A therapy in oncology and ophthalmology, valued for its potent anti-angiogenic effects across cancer and ocular diseases. Beyond angiogenesis, growing evidence suggests that VEGF-A also contributes to neuronal homeostasis, including autophagy regulation, synaptic plasticity, and nociceptive ...
Cheng Li, Zhiwei Xu, Quan Ma, See PDF
openaire +1 more source
Cheng Li, Zhiwei Xu, Quan Ma, See PDF
openaire +1 more source
Mechanistic Target of Rapamycin (mTOR) in Tuberous Sclerosis Complex-Associated Epilepsy
Pediatric Neurology, 2015Paolo Curatolo
exaly
Mechanistic Target of Rapamycin Complex 1 (mTORC1) Activity in an In Vitro Model of AKI
Journal of the American Society of NephrologyAsha Rath, Sian E. Piret
openaire +1 more source
Mammalian Target of Rapamycin Signaling in Cardiac Physiology and Disease
Circulation Research, 2014Sebastiano Sciarretta +2 more
exaly

